Clinical effects of phospholipase D2 in attenuating acute pancreatitis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-6)

Sum=110

Publishing Process of This Article

Item

Count

Browse

Download

Sum=20

Jan 14, 2025 (publication date) through Dec 21, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jan 14, 2025; 31(2): 97239
Published online Jan 14, 2025. doi: 10.3748/wjg.v31.i2.97239

Table 6 In vitro migration test of neutrophils

Group	Number of neutrophil migration (n)
Mild group (n = 25)	212.24 ± 24.66
Mild group + PLD2 inhibitor group (n = 25)	473.69 ± 35.17
Moderate group (n = 30)	536.19 ± 44.58
Moderate group + PLD2 inhibitor group (n = 30)	755.03 ± 50.19
Severe group (n = 35)	828.61 ± 58.21
Severe group + PLD2 inhibitor group (n = 35)	1126.75 ± 64.38
Variance ratio	16.204
P value	0.001

PLD2: Phospholipase D2.

Citation: Niu JW, Zhang GC, Ning W, Liu HB, Yang H, Li CF. Clinical effects of phospholipase D2 in attenuating acute pancreatitis. World J Gastroenterol 2025; 31(2): 97239
URL: https://www.wjgnet.com/1007-9327/full/v31/i2/97239.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i2.97239